Ensuring quality in the handling of clinical materials for mpox research
Official title: Division of Microbiology and Infectious Diseases (DMID): Clinical Materials Services (CMS): mpox Studies
Funded at Fisher Bioservices, INC. · NIH-11202794 · Data updated 2026-11-12
This study is all about making sure that the materials used in mpox research are handled safely and correctly, which can help improve the quality of clinical trials and ultimately lead to better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fisher Bioservices, INC. NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project start | September 21, 2022 |
| Project end | September 20, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,000,000 |
| NIH project number | 75N93022C00023-P00003-9999-4 |
| Project ID | NIH-11202794 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals involved in or affected by mpox and related infectious diseases.
✕Less likely to help
Patients not affected by mpox or those who do not participate in clinical trials may not receive direct benefits from this research.
What this research studies
This research focuses on maintaining high standards in the handling of clinical materials related to mpox, ensuring that all processes meet Good Manufacturing Practice (cGMP), Good Clinical Practice (GCP), and Good Laboratory Practice (GLP) guidelines. It involves the acquisition, receipt, storage, and shipping of clinical agents and specimens to support clinical trials and research programs. Patients may benefit from the improved quality and reliability of clinical trials that utilize these materials, which can lead to better treatment outcomes. The research is conducted by Fisher Bioservices, Inc., located in Rockville, United States.
Why it matters
Potential benefit: If successful, this research could enhance the quality and reliability of clinical trials for mpox, leading to improved treatment options for patients.
How similar studies have gone: Other research has shown success in improving clinical trial outcomes through adherence to stringent quality standards, making this approach well-supported by previous findings.
Where this research is happening
-
Fisher Bioservices, INC.
Rockville, United States Active
Researchers
- Principal investigator: Eyler, Dennis — Fisher Bioservices, INC.
- Study coordinator: Eyler, Dennis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.